Print

TRANSGENE (TRGNY) Says Experimental Cancer Drug Has ‘Enormous Potential’  
3/16/2011 7:28:43 AM

Bloomberg -- Transgene SA (TNG), a French biotechnology company, is “very confident” about the prospects of an experimental cancer treatment now in clinical testing, Chief Executive Officer Philippe Archinard said.
//-->